Search scope:
排序： Display mode:
Frontiers of Medicine 2022, Volume 16, Issue 6, Pages 909-918 doi: 10.1007/s11684-021-0890-1
Keywords： acute promyelocytic leukemia intracranial hemorrhage cytokines biomarker
Frontiers of Medicine 2021, Volume 15, Issue 6, Pages 887-902 doi: 10.1007/s11684-021-0879-9
Keywords： microRNAs monocarboxylate transporter 1 motor training subarachnoid hemorrhage white matter injury
Marie-Germaine Bousser
Frontiers of Medicine 2012, Volume 6, Issue 1, Pages 22-34 doi: 10.1007/s11684-012-0178-6
Stroke is a personal, familial, and social disaster. It is the third cause of death worldwide, the first cause of acquired disability, the second cause of dementia, and its cost is astronomic. The burden of stroke is likely to increase given the aging of the population and the growing incidence of many vascular risk factors. Prevention of stroke includes—as for all other diseases—a “mass approach” aiming at decreasing the risk at the society level and an individual approach, aiming at reducing the risk in a given subject. The mass approach is primarily based on the identification and treatment of vascular risk factors and, if possible, in the implementation of protective factors. These measures are the basis of primary prevention but most of them have now been shown to be also effective in secondary prevention. The individual approach combines a vascular risk factor modification and various treatments addressing the specific subtypes of stroke, such as antiplatelet drugs for the prevention of cerebral infarction in large and small artery diseases of the brain, carotid endarterectomy or stenting for tight carotid artery stenosis, and oral anticoagulants for the prevention of cardiac emboli. There is a growing awareness of the huge evidence-to-practice gap that exists in stroke prevention largely due to socio-economic factors. Recent approaches include low cost intervention packages to reduce blood pressure and cheap “polypills” combining in a single tablet aspirin and several drugs to lower blood pressure and cholesterol. Polypill intake should however not lead to abandon the healthy life-style measures which remain the mainstay of stroke prevention.
Keywords： stroke prevention vascular risk factors cerebral infarction cerebral hemorrhage anti-thrombotic drugs
ZHAO Jizong, WANG Dejiang, WANG Shuo, YUAN Ge, KANG Shuai, JI Nan, ZHAO Yuanli, YE Xun, ZHOU Liangfu, ZHOU Dingbiao, WANG Renzhi, WANG Mei
Frontiers of Medicine 2007, Volume 1, Issue 2, Pages 142-146 doi: 10.1007/s11684-007-0027-1
Keywords： tomographic-guided aspiration single-blinded manner favorable outcome operation Glasgow
Giant renal angiomyolipoma with tuberous sclerosis complex
Ouyan SHI PhD, Guodong XU BM, Chunxiang WANG BM,
Frontiers of Medicine 2009, Volume 3, Issue 4, Pages 495-498 doi: 10.1007/s11684-009-0068-8
Keywords： renal angiomyolipoma tuberous sclerosis complex hemorrhage
Emergency adult living donor right lobe liver transplantation for fulminant hepatic failure
ZHANG Feng, WANG Xuehao, LI Xiangcheng, KONG Lianbao, SUN Beicheng, LI Guoqiang, QIAN Xiaofen, CHEN Feng, WANG Ke, LU Sheng, PU Liyong, LU Ling
Frontiers of Medicine 2007, Volume 1, Issue 3, Pages 282-286 doi: 10.1007/s11684-007-0054-y
Keywords： alimentary abnormal hemorrhage principal different
Title Author Date Type Operation
Predictive values of plasma TNFα and IL-8 for intracranial hemorrhage in patients with acute promyelocytic
Journal Article
Loss of monocarboxylate transporter 1 aggravates white matter injury after experimental subarachnoid hemorrhage
Journal Article
Comparison of CT-guided aspiration to key hole craniotomy in the surgical treatment of spontaneous putaminal hemorrhage
ZHAO Jizong, WANG Dejiang, WANG Shuo, YUAN Ge, KANG Shuai, JI Nan, ZHAO Yuanli, YE Xun, ZHOU Liangfu, ZHOU Dingbiao, WANG Renzhi, WANG Mei
Journal Article
Giant renal angiomyolipoma with tuberous sclerosis complex
Ouyan SHI PhD, Guodong XU BM, Chunxiang WANG BM,
Journal Article
京公网安备 11010502051620号
